Cited by 1,200Dermatology and Skin DiseasesReliability and Agreement in MeasurementContact Dermatitis and Allergies

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., Evaluator Group, The Easi·2001·Experimental Dermatology

DOI 10.1034/j.1600-0625.2001.100102.x

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. DESIGN: Training of evaluators, application, and assessment over 2 consecutive days. SETTING: An academic center. PATIENTS: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years). INTERVENTIONS: None. MAIN OUTCOME MEASURE: The EASI was used by 15 dermatologist evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. RESULTS: Overall intra-evaluator reliability of the EASI was in the fair-to-good range. Inter-evaluator reliability analyses indicated that the evaluators assessed the patients consistently across both study days. CONCLUSIONS: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.

Integrity signals

Registry

Crossref · 10.1034/j.1600-0625.2001.100102.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Self-citation
The Design and Analysis of Clinical Experiments
Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,304
Large sample standard errors of kappa and weighted kappa.
Fleiss, J. L., Cohen, J., & Everitt, B. S. (1969) · Psychological Bulletin · doi:10.1037/h0028106 · Cited by 1,536
Grading of the severity of atopic dermatitis.
Rajka, G., & Langeland, T. (1989) · PubMed · doi:10.2340/000155551441314 · Cited by 415
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis
Sowden, J. M., Allen, B. R., Berth‐Jones, J., GRAHAM-BROWN, R. A. C., Motley, R., Finlay, A. Y., Salek, S., Marks, R., Ross, J., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children
Kang, S., Lucky, A. W., Pariser, D. M., Lawrence, I., & Hanifin, J. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109812 · Cited by 329
Self-citation
A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients
Paller, A. S., Eichenfield, L. F., Leung, D. Y. M., Stewart, D., & Appell, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109813 · Cited by 323
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy
Hanifin, J. M., LING, M. R., Langley, R. G. B., Breneman, D., & Rafal, E. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109810 · Cited by 285
Self-citation

Show all 17 references

Research works printed but not linked: 1

Fleiss J L, 1986, New York., 1

Sorted by citations

Items 901–1,000 of 1,000

Les scores d’évaluation de la dermatite atopique
Lacour, J. ‐. (2020) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(20)31083-8 · Cited by 3
Efficacy of dupilumab in moderate and severe atopic dermatitis
Weidinger, S., Simpson, E. L., Silverberg, J. I., Schmitt, J. M., Leshem, Y. A., Katoh, N., Chen, Z., Zhang, H., Shumel, B. S., Bansal, A., et al. (2023) · JEADV Clinical Practice · doi:10.1002/jvc2.100 · Cited by 3
Juckreiz, Schlafstörungen, depressive Symptome, Fatigue und Einschränkungen der Arbeitsproduktivität bei Patienten mit moderater bis schwerer atopischer Dermatitis: Daten aus dem TREATgermany‐Register
Birkner, T., Siegels, D., Heinrich, L., Haufe, E., Abraham, S., Heratizadeh, A., Harder, I., Bell, M., Fell, I., Worm, M., et al. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15159_g · Cited by 3
Real-world clinical efficacy of nemolizumab in Japanese patients with atopic dermatitis
Watanabe, Y., Ishiuji, Y., Ogawa‐Tominaga, M., Katsuta, M., & Asahina, A. (2023) · Itch · doi:10.1097/itx.0000000000000071 · Cited by 3
Clinical Experience in Children
Prost, Y. D. (2004) · Springer eBooks · doi:10.1007/978-3-662-10209-1_9 · Cited by 3
Drug Class Review: Topical Calcineurin Inhibitors
Lee, E., McDonagh, M. S., Chan, B. K. S., Peterson, K., & Thakurta, S. (2008) · Cited by 3
Improvement of Out-in skin Transparency and Symptoms by Shower Therapy in Children with Atopic Dermatitis
Mochizuki, S. T. H. (2012) · Pediatrics & Therapeutics · doi:10.4172/2161-0665.1000115 · Cited by 3
Severe, chronic and recalcitrant atopic dermatitis associated with Tinea capitis: Diagnostic approach and effects of topical Vernonia amygdalina Del. extracts
Ngatu, N. R., Mukuamu, M., Hirota, R., Nangana, L. S., Longo‐Mbenza, B., & Suganuma, N. (2014) · Cited by 3
THE ROLE OF GENETIC DETERMINANTS AND DISORDERS IN SYSTEMIC AND LOCAL IMMUNITY IN THE ETIOLOGY AND PATHOGENESIS OF HERPETIC ECZEMA (KAPOSI'S ECZEMA)
Stadnikova, A. S., Тамразова, О. Б., & Chebotareva, T. A. (2016) · CHILDREN INFECTIONS · doi:10.22627/2072-8107-2016-15-3-42-45 · Cited by 3
Eczema Skin Lesions Segmentation Using Deep Neural Network (U-Net)
Nisar, H., Tan, Y. R., & Yeap, K. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-23239-8_10 · Cited by 3
Pimecrolimus for the treatment of atopic dermatitis
Breuer, K., Werfel, T., & Kapp, A. (2005) · Therapy · doi:10.1586/14750708.2.1.37 · Cited by 3
General Guidelines for Assessment of Skin Diseases
Holm, E. (2006) · CRC Press eBooks · doi:10.3109/9781420003307-131 · Cited by 3
General Aspects of Treatment
Finlay, A. Y., & Smith, C. H. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch72 · Cited by 3
Emollients for eczema
Oranje, A. P., der Spek, F. B. D. W., Ordonez, C. P., Raeve, L. E. D., Spierings, M., & van der Wouden, J. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008304 · Cited by 3
Retracted
The clinical and laboratory findings of infants with atopic dermatitis during diagnosis and follow-up
Chousein, A., Şenol, H. D., Özdoğru, E. E., Akarcan, S. E., & Tunçel, T. (2023) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.281 · Cited by 2
Consideration of treatment goals and termination algorithm for adolescent atopic dermatitis using upadacitinib
Koga, T., Okada, K., Shimizu, T., Morita, E., & Itazawa, T. (2024) · Journal of Cutaneous Immunology and Allergy · doi:10.3389/jcia.2024.13404 · Cited by 2
[Translated article] Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial
Silvestre, J., Ruíz‐Villaverde, R., Pérez‐García, B., Pinto, P. H., Dominguez‐Cruz, J. J., Gentile, M., & Belloso, R. M. I. (2024) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2024.10.015 · Cited by 2
Interobserver Agreement of the Eczema Area and Severity Index for Atopic Dermatitis Severity Assessment: A Real-World Evidence Study
Villa-González, J. M., Gonzalez-Hermosa, M. R., Alzaga, J. U., Blasco, R. P., Ibarrola, P. A., Atxutegi‐Ayesta, X., García, A. G., Aguirre, I. I., del Tánago, B. U. G., Ares, M. P., et al. (2025) · Dermatitis · doi:10.1089/derm.2025.0054 · Cited by 2
The interaction between the expression of CD23 molecule on B- lymphocytes and the level of specific IgE against molecular components of pollen in atopic dermatitis patients with and without dupilumab therapy
Čelakovská, J., Čermáková, E., & Boudková, P. (2025) · Journal of Immunotoxicology · doi:10.1080/1547691x.2025.2507311 · Cited by 2
New topical molecular targeted therapies for atopic dermatitis in children: A systematic review and meta‐analysis
Murai, H., Kawamoto, N., Arima, T., Okada, Y., Takeuchi, H., Miyamoto, M., Yamamoto‐Hanada, K., Futamura, M., Saeki, H., & Ohya, Y. (2025) · Pediatric Allergy and Immunology · doi:10.1111/pai.70122 · Cited by 2
Cost-Per-Responder Analysis for Tralokinumab and Dupilumab in Combination with Topical Corticosteroids in Patients with Moderate-To-Severe Atopic Dermatitis
Wiseman, M., Benvenuto, M., Strømkjær, L., Paludan‐Müller, A. S., Ryttig, L., Petersen, A. S., & Wollenberg, A. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01565-1 · Cited by 2
Transitioning from Cyclosporine to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World Comparison of Direct Switch vs. Short Overlap
Ureña‐Paniego, C., la Torre, R. S.-D., Arias‐Santiago, S., & Montero‐Vílchez, T. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15110515 · Cited by 2
Long-term efficacy and safety of topical therapy in pediatric moderate to severe atopic dermatitis (ROAD study)
Yaguchi, T., Toyokuni, K., Jimbo, C., Hagino, K., Harama, D., Omori, M., Suzuki, D., Umezawa, K., Shimada, M., Ogasawara, H., et al. (2025) · Allergology International · doi:10.1016/j.alit.2025.11.005 · Cited by 2
The Combination of Mineral Salts and Natural Antioxidants Agents Is Highly Effective in Atopic Dermatitis
Yori, F., Sarmiento, C., Beltrán, J. G., & Umbert, I. J. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s562171 · Cited by 2
A preclinical study of device dependent therapeutic effects of cold atmospheric plasmas on atopic dermatitis induced by DNCB
Shakeri, F., Mehdian, H., Bakhtiyari-Ramezani, M., Hajisharifi, K., & Amini, E. (2026) · Scientific Reports · doi:10.1038/s41598-026-36821-7 · Cited by 2
Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trials
Wollenberg, A., Simpson, E. L., Leshem, Y. A., Taı̈eb, A., Katoh, N., Chao, J., Rossi, A. B., & Praestgaard, A. H. (2026) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.70310 · Cited by 2
Topical probiotic Lactobacillus lactis treatment in atopic dermatitis: a placebo-controlled pilot study on tolerability and efficacy
Salo, V., Remitz, A., Lauerma, A., & Salava, A. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1694229 · Cited by 2
Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD Registry
Zhang, L., Zhou, N., Wu, Z., Chen, X., Zhu, H., Li, S., Han, J., Miao, G., Wu, L., Zhu, R., et al. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01655-8 · Cited by 2
Untangling the Complexity of Childhood Atopic Dermatitis: Phenotypes and Endotypes
Dumycz, K., Zygadło, J., Marzec, A., Strus, P., Kulus, M., Sokołowska, M., Venter, C., Leung, D. Y. M., & Feleszko, W. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09128-0 · Cited by 2
Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
Gay-Mimbrera, J., Aguilar-Luque, M., Gómez‐Arias, P. J., Rivera‐Ruiz, I., García, F. J., Juan-Cencerrado, M., Mochón‐Jiménez, C., Parra-Peralbo, E., Ruíz‐Villaverde, R., Liñares-Blanco, J., et al. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01657-6 · Cited by 2
Atopic Dermatitis
Boguniewicz, M., & Leung, D. Y. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00035-8 · Cited by 2
Case study of clinical improvement of atopic dermatitis in a patient treated with herbal-based parapharmaceuticals
Maraschio, A., Wulhfard, K., & Monsellato, L. (2023) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2023-0005 · Cited by 2
Ganzkörper‐Blaulichtbestrahlung zur Behandlung der atopischen Dermatitis: eine randomisierte, placebokontrollierte klinische Studie (AD‐Blue)
Buhl, T., Santana, M. S., Forkel, S., Kromer, C., Seidel, J., Möbs, C., Pfützner, W., Pfeiffer, S., Laubach, H., Boehncke, W., et al. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15211_g · Cited by 2
Sleep improvements following atopic dermatitis management in young children
Mindell, J. A. A., Leichman, E. S., Parikh-Das, A. M., Lee, C., & Aquilina, J. W. (2023) · Sleep Health · doi:10.1016/j.sleh.2023.10.015 · Cited by 2
Skin care by washing with water is not inferior to washing with a cleanser in children with atopic dermatitis in remission in summer: WASH study
Katoh, Y., Natsume, O., Yasuoka, R., Hayano, S., Okada, E., Ito, I., Sakai, A., Monna, Y., Takayanagi, F., Inuzuka, Y., et al. (2024) · Allergology International · doi:10.1016/j.alit.2024.01.007 · Cited by 2
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores between Different Phenotypes of Atopic Dermatitis in Patients before and after Biologic Therapy with Dupilumab
Russo, F., Cioppa, V., Lazzeri, L., Milanesi, N., Galluzzo, M., D’Erme, A. M., Schettini, N., Cocuroccia, B., Sordi, D., Panebianco, A., et al. (2024) · Dermatitis · doi:10.1089/derm.2023.0357 · Cited by 2
Do Psoriasis and Atopic Dermatitis Affect Memory, Attention, Stress and Emotions?
Kuryłło, M., Mojs, E. H., Woźniak, N., & Wiśniewska-Szeplewicz, D. (2024) · Brain Sciences · doi:10.3390/brainsci14080747 · Cited by 2
A real-world study of the longitudinal course of itch severity and frequency in adults with atopic dermatitis
Hong, M. R., Lei, D. K., Yousaf, M., Chavda, R., Gabriel, S., Janmohamed, S. R., & Silverberg, J. I. (2021) · Archives of Dermatological Research · doi:10.1007/s00403-021-02214-1 · Cited by 2
Selectin Dependence of Allergic Skin Inflammation Is Diminished by Maternal Atopy
Khan, I., Ulrich, B. J., Nelson, A. S., Sehra, S., Kansas, G. S., & Kaplan, M. H. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100052 · Cited by 2
Association of Adult Atopic Dermatitis Severity with Bacterial, Viral, and Fungal Skin Infections
Rios-Duarte, J. A., & Silverberg, J. I. (2023) · Dermatitis · doi:10.1089/derm.2022.29006.jrd · Cited by 2
Solving the health disparity of eczema assessment: A role for skin tape soluble protein?
Visitsunthorn, K., Atwal, S., Lopez, E., & Ong, P. Y. (2023) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2023.100180 · Cited by 2
Clinical efficacy and safety of autologous serum intramuscular injection in patients with mild-to-moderate atopic dermatitis: a prospective, open-label, uncontrolled study
Choi, G., Park, J. B., Kim, Y.-H., & Kim, H.-K. (2024) · Kosin Medical Journal · doi:10.7180/kmj.24.101 · Cited by 2
Assessing eczema severity: A comprehensive review of scoring systems
Suresh, M. S., & Kaliyadan, F. (2024) · Indian Journal of Skin Allergy · doi:10.25259/ijsa_50_2024 · Cited by 2
Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
Mendes‐Bastos, P., Lazaridou, E., Torres, T. R., Aggelakopoulos, C., Katsantonis, I., Aronis, P., Rigopoulos, D., Azevedo, F., Santiago, F., Papakonstantis, M., et al. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01414-1 · Cited by 2
Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
Huang, C., & Sheng, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093095 · Cited by 2
Retracted
Use of Moisturizers in Patients with Atopic Dermatitis
Hon, K. E., & Leung, A. K. C. (2012) · Springer eBooks · doi:10.1007/978-3-642-27606-4_5 · Cited by 2
Prescribing for children with atopic eczema in primary care
Penzer, R. (2015) · Nurse Prescribing · doi:10.12968/npre.2015.13.7.326 · Cited by 2
Assessment of the efficacy of a metabolic drug in combined therapy of eczema
Ласеев, Д. И., Дикова, О. В., Laseeva, M. G., & Коваленко, А. Л. (2015) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma201514248-55 · Cited by 2
Beneficial Effect of Diet Intervention on School Children with Atopic Dermatitis
Lee, J. H., Hong, S. W., Kim, S.-A., Choi, H. J., Kim, M. K., & Suh, Y. S. (2016) · Daehan imsang geon-gang jeungjin hakoeji/Daehan imsang geon'gang jeungjin haghoeji · doi:10.15384/kjhp.2016.16.1.32 · Cited by 2
Effectiveness of soap in fall-winter for maintaining remission of eczema in children with atopic dermatitis
Inuzuka, Y., Kato, Y. H., Sakai, A., Taguchi, T., & Natsume, O. (2018) · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology · doi:10.3388/jspaci.32.249 · Cited by 2
Advanced Capnography Sampling Lines May Improve Patient Comfort and Compliance
Blonder, Y., Mazor, E., & Jew, K. (2021) · Medical Devices Evidence and Research · doi:10.2147/mder.s292526 · Cited by 2
Treatment outcomes of patients with Atopic Dermatitis (AD) treated with dupilumab through the Early Access to Medicines Scheme (EAMS) in the UK.
O’Kane, D., Davis, L., Ardern‐Jones, M. R., Laws, P., Shaw, L., Cork, M. J., Velangi, S., Cooper, H. L., Hudson, R. D. A., Smith, A. B., et al. (2021) · PubMed Central · Cited by 2
Electroacupuncture for relieving itching in atopic eczema: study protocol for a multicenter, randomized, sham-controlled trial
Wang, S., Liang, R.-L., Yang, H., Cai, X., Wang, J., Sun, X., Chen, J.-L., Wang, C., Jiang, W., & Li, X. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1320230 · Cited by 2
Assessing Quality of Ordinal Scales Depicting Skin Aging Severity
Valet, F., Ezzedine, K., Malvy, D. J.-M., Mary, J., & Guinot, C. (2015) · Springer eBooks · doi:10.1007/978-3-642-27814-3_87-2 · Cited by 2
Pruni Cortex Extract Accelerates Wound Healing in a Mouse Model of Atopic Dermatitis
Nomoto, M. (2017) · Journal of Nutritional Disorders & Therapy · doi:10.4172/2161-0509.1000220 · Cited by 2
Assessment of atopic eczema severity with EASI
Rob, F., & Hercogova, J. T. (2020) · Dermatologie pro praxi · doi:10.36290/der.2020.001 · Cited by 2
Atopisk eksem
Berents, T. L., Saunes, M., Schopf, T., & Vindenes, H. K. (2018) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.18.0071 · Cited by 2
Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema
Apfelbacher, C., Jupiter, A., Carter, B., Weißhaar, E., & Böhmer, M. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012167 · Cited by 2
Eczematous skin reaction after intravenous immunoglobulin therapy in axonal Guillain-Barré syndrome
Oh, S., Seol, J. E., Hong, S. M., Kim, H., Kim, S. J., Shin, K. J., Kim, J. K., Yoon, B., & Bae, J. S. (2022) · Neurology Asia · doi:10.54029/2022aex · Cited by 2
The Burden of Atopic Dermatitis on Children and Their Families : Quality of Life and Financial Impact in Seoul Area
Yu, S.-M., & Choi, I.-H. (2010) · The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology · Cited by 2
Atopic Dermatitis: Scoring Severity and Quality of Life Assessment
Lewis‐Jones, M. S., & Charman, C. R. (2011) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781444345384.ch29 · Cited by 2
Adaptação cultural e validação do módulo específico dermatite atópica do instrumento de avaliação de qualidade de vida relacionada à saúde de crianças e adolescentes - DISABKIDS® - MDA - Fase I
Deon, K. C. (2009) · doi:10.11606/d.22.2009.tde-29102009-143802 · Cited by 2
Clinical Experience in Adults
Reitamo, S. (2004) · Springer eBooks · doi:10.1007/978-3-662-10209-1_8 · Cited by 2
Principles of Measurement and Assessment in Dermatology
Finlay, A. Y. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0016 · Cited by 2
Microbial extract as a nature exposure material reduces the need for atopic dermatitis medicationPreprint
Kalmari, J. E., Mäkelä, I., Hytönen, V. P., Huhtala, H., Hyöty, H., Laitinen, O. H., & Sinkkonen, A. (2025) · medRxiv · doi:10.1101/2025.04.04.25325234 · Cited by 2
Hidden immune memory niches in inflammatory skin diseasesPreprint
Steele, L., Foster, A. R., Roberts, K., Admane, C., Birk, S., Mazin, P., Akbarnejad, A., Tudor, C., Rumney, B. M., Chan, H. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.20.713219 · Cited by 2
Exploring Standardized Scales and Serum Biomarkers to Evaluate Changes in Pruritus due to Eczema after Japanese Kampo Treatment: A Prospective Case Series
Yoshino, T., Horiba, Y., Mimura, M., & Watanabe, K. (2022) · Complementary Medicine Research · doi:10.1159/000524778 · Cited by 1
Kestose Increases the Relative Abundance of Faecalibacterium spp. and Nominally Increases Cow Milk Tolerant Dose in Children with Cow's Milk Allergy – Preliminary Results
Kubota, S., Sugiura, S., Takahashi, M., Kadota, Y., Takasato, Y., Matsui, T., Kitamura, K., Tochio, T., & Ito, K. (2023) · Polish Journal of Microbiology · doi:10.33073/pjm-2023-030 · Cited by 1
Psychosocial Burden in People with Atopic Dermatitis: Effects of a Substance-Free Basic Skincare in a Randomized Health Care Study
von Stülpnagel, C. C., Augustin, M., Sommer, R., & Westphal, L. (2023) · Skin Pharmacology and Physiology · doi:10.1159/000536671 · Cited by 1
Unilateral Osteonecrosis of the Femoral Head in a Patient with Atopic Dermatitis Due to Uncontrolled Topical Steroid Treatment, a Case Report
Weinberger, D. G., Kotrulja, L., Ramić, S., Sesar, P., & Babić, S. (2025) · Reports — Medical Cases Images and Videos · doi:10.3390/reports8020065 · Cited by 1
Therapeutic efficacy of Sanhuang Xiexin decoction on atopic dermatitis via suppressing STAT3 signaling
Yan, X., Cheng, L., Zhi, G., Che, M., Shen, H., Du, Z., Ma, X., Geng, F., & Li, B. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120993 · Cited by 1
Dysregulated Iron Homeostasis in Atopic Dermatitis: Linking Iron Deficiency to Clinical Severity and Quality of Life
Ponikowska, M., Jankowska‐Konsur, A., & Lewandowski, Ł. (2025) · Nutrients · doi:10.3390/nu17233743 · Cited by 1
Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab
Cioppa, V., Lazzeri, L., Carraro, A., PIANO, E. D., Falcinelli, F., Galluzzo, M., Pallotta, S., Pità, O. D., & Russo, F. (2023) · Dermatitis · doi:10.1089/derm.2023.0052 · Cited by 1
Impact of atopic dermatitis lesion locations and extent on patient burden: A real‐world study
Simpson, E. L., Lio, P., Pierce, E. J., Cronin, A. M., McLean, R. R., Eckmann, T., Atwater, A. R., Dawson, Z., & Silverberg, J. I. (2024) · JEADV Clinical Practice · doi:10.1002/jvc2.413 · Cited by 1
Disease burden, clinical management and unmet treatment need of patients with moderate to severe atopic dermatitis; consensus statements, insights and practices from CERTADE (Central/Eastern EU, Russia, Turkiye AD Experts) Delphi panel
Trzeciak, M., Rudnicka, L., Arenberger, P., Engіn, B., Lvov, A. N., Alper, S., Alpsoy, E., Benáková, N., Bobko, S., Borlu, M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1402493 · Cited by 1
Validation of IGA*BSA in Assessing Disease Severity and Response in Patients with Atopic Dermatitis: A Retrospective Cohort Study in China
Yang, C., Wu, X., He, J., Liao, Y., Chen, J., & Dou, X. (2024) · Dermatitis · doi:10.1089/derm.2024.0226 · Cited by 1
Effect of house dust mite sublingual immunotherapy in patients with adult atopic dermatitis with rhinitis
Mizuno, M., Imamura, S., Yoshioka, A., Washio, K., Oda, Y., Matsuhara, H., Ohashi‐Doi, K., & Fukunaga, A. (2024) · Future Science OA · doi:10.1080/20565623.2024.2419779 · Cited by 1
Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case Series
Rossi, A. B., Mello, A. M., & Zahn, J. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03150-6 · Cited by 1
Assessing Atopic Dermatitis Control in Chinese Patients: Validation of the Chinese Version of Recap of Atopic Eczema Questionnaire (RECAP) and an Investigation into Its Interpretability
Zhang, J., Zhu, S., Yuan, L., Yu, X., Ling, S., Zhang, J., & Yang, B. (2025) · Acta Dermato Venereologica · doi:10.2340/actadv.v105.43458 · Cited by 1
Interaction between expression of CD23 on B-lymphocytes and level of specific IgE against molecular components of NPC2 family, lipocalins, uteroglobins, and molecular components of molds and yeast
Čelakovská, J., Boudková, P., Čermáková, E., & Andrýs, C. (2025) · Journal of Immunotoxicology · doi:10.1080/1547691x.2025.2531794 · Cited by 1
The effects of Chinese botanical lotion and pimecrolimus cream in the treatment of chronic perianal eczema: a randomized clinical trial
Lai, L., Wang, Y., Wen, L., Wang, S., Chen, S., Gu, C., & Zhang, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1673112 · Cited by 1
Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison
Chovatiya, R., Armstrong, A. W., Kircik, L., Puig, L., Kirchhof, M. G., Torres, T. R., Binamer, Y., Duarte, G. V., Akmaz, B., Dossenbach, M. R. K., et al. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01620-x · Cited by 1
Influencing factor analysis and prediction model construction of dupilumab treatment adherence: a prospective cohort study in moderate-to-severe atopic dermatitis
Ouyang, P., Yan, S., Zeng, J., Gao, L., Tan, L., & Lu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682777 · Cited by 1
How Adequately is the Severity of Atopic Dermatitis Assessed by Resident Physicians Training in Dermatology? Evaluation of the Intrarater and Interrater Reliability of Clinical Scoring Systems (EASI, oSCORAD, IGA, TIS Score, SASSAD)
Waligóra-Dziwak, K., Kubiak, K. B., Dańczak‐Pazdrowska, A., & Jenerowicz, D. (2026) · Acta Dermato Venereologica · doi:10.2340/actadv.v106.43964 · Cited by 1
Model‐informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis
Fauchet, F., Largajolli, A., Jauslin, P. M., Schindler, E., Hamimed, M., Kantasiripitak, W., Gonçalves, A., van Maanen, E., Benkali, K., Saito, T., et al. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70435 · Cited by 1
Self-citation
Multidisciplinary Delphi Consensus on management of children with moderate-severe atopic dermatitis
Marseglia, G. L., Tosca, M. A., del Giudice, M. M., Fortina, A. B., Bonamonte, D., Neri, I., Peroni, D. G., D’Avino, A., Comberiati, P., Filippeschi, C., et al. (2026) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-026-02212-x · Cited by 1
Biologic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Bayesian Network Meta-Analysis of Established and Investigational Agents
Babul, A., Mehta, D., Soliman, Y. S., Hussain, M., & Babul, N. (2026) · Cureus · doi:10.7759/cureus.105706 · Cited by 1
Serum proteomic changes in atopic dermatitis patients treated with cyclosporine
Olydam, J. I., Litman, T., Nijsten, T. E. C., Hoof, I., Koopmann, W., Pardo, L. M., & Hijnen, D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346686 · Cited by 1
Preterm birth is associated with reduced risk of atopic dermatitis and a distinct allergic comorbidity profile in early childhood
Ruge, I. F., Nielsen, M., Halling, A., Gerner, T., Rinnov, M. R., Trautner, S., Thomsen, S. F., Skov, L., Egeberg, A., Jakaša, I., et al. (2026) · British Journal of Dermatology · doi:10.1093/bjd/ljag167 · Cited by 1
Atopic Dermatitis: Contemporary Concepts in Epidemiology, Pathogenesis, Assessment, and Targeted Treatment
Jin, C., DING, Z., Chien, P. N., & Heo, C. Y. (2026) · Allergies · doi:10.3390/allergies6020016 · Cited by 1
Severity outcome measures in patients with skin of color: Gaps in current scoring systems and opportunities for improvement
Hwang, S., Stark, M., Taylor, S. C., Rodrigues, M., Alexis, A. F., & Murrell, D. F. (2026) · JAAD reviews. · doi:10.1016/j.jdrv.2026.05.005 · Cited by 1
Messung der Erkrankungsschwere in der Dermatologie
Deckert, S., Apfelbacher, C., & Schmitt, J. M. (2015) · Der Hautarzt · doi:10.1007/s00105-015-3663-4 · Cited by 1
The Significance of Atopic Dermatitis
Wallach, D. (2016) · Journal of Dermatological Research · doi:10.17554/j.issn.2413-8223.2016.01.5 · Cited by 1
The Efficacy Of Using Tacrolimus Ointment On Children With Atopic Dermatitis
Mohammad, S., & Siddiqui, M. (2012) · Cited by 1
[BIOMARKER FOR ATOPIC DERMATITIS IN CHILDREN：FOCUSING ON TARC AND NOVEL SCCA2].
Fujisawa, T. (2018) · PubMed · doi:10.15036/arerugi.67.981 · Cited by 1
Modern approaches to prevention and treatment of dermatological diseases under inﬂuence of secondary precious metals production factors
Васильевна, Я. И., Moiseeva, I. V., & Saarkoppel, L. M. (2019) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2018-9-4-9 · Cited by 1
Eczema with secondary infection in elderly patients in the outpatient practice of a dermatovenerologist
Khardikova, S. A. (2020) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202019041539 · Cited by 1
Clinicopathological Differences between Acquired Reactive Perforating Collagenosis and Prurigo Nodularis
Kawamura, M., Inoue, M., Matsuyama, K., Mizutani, Y., Shu, E., Miyazaki, T., & Seishima, M. (2021) · Journal of Clinical & Experimental Dermatology Research · doi:10.35248/2155-9554.21.s8.550 · Cited by 1
The Moisturizing Effects of the Cosmetic Products Containing Herbs Extract on Infant Skin
Lee, J. G., Lee, J.-S., Park, H., Cho, W., Kim, M.-R., Ha, I.-D., Kim, K.-J., Hwang, S.-Y., & Jee, S.-Y. (2008) · The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology · Cited by 1
Atopic Dermatitis and Allergic Contact Dermatitis
Boguniewicz, M., Fonacier, L. S., & Leung, D. Y. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-80912-2.00011-1 · Cited by 1

Authors: Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E.
Affiliations: Oregon Health & Science University (US)
Novartis (Switzerland) (CH)
Shiga University of Medical Science (JP)
Corresponding author: Hanifin, J. M.
ORCID: Hanifin, J. M.
Venue: Experimental Dermatology
Publisher: Wiley
Published: 2001-02
Volume: 10
Issue: 1
Pages: 11-18
ISSN: 0906-6705 (ISSN-L)
1600-0625
DOI: 10.1034/j.1600-0625.2001.100102.x
OpenAlex: W2117359358
Cited by: 1,200
References: 17
Citations by year: 2026: 69 · 2025: 85 · 2024: 92 · 2023: 101 · 2022: 84 · 2021: 98 · 2020: 82 · 2019: 63 · 2018: 47 · 2017: 46 · 2016: 53 · 2015: 28 · 2014: 43 · 2013: 23 · 2012: 21
FWCI: 20.78
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2713 d)
Locations: Experimental Dermatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Keywords: Eczema Area and Severity Index, atopic dermatitis, inter-rater reliability, intra-rater reliability, disease severity assessment, disease extent assessment, clinical trial outcome measures
MeSH terms: Adolescent, Adult, Child, Child, Preschool, Dermatitis, Atopic, Dermatology, Eczema, Humans, Infant, Infant, Newborn, Severity of Illness Index, Reproducibility of Results, Cohort Studies, Observer Variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks